| UniProt ID | SNX1_MOUSE | |
|---|---|---|
| UniProt AC | Q9WV80 | |
| Protein Name | Sorting nexin-1 | |
| Gene Name | Snx1 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 522 | |
| Subcellular Localization |
Endosome membrane Peripheral membrane protein Cytoplasmic side. Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein Cytoplasmic side . Early endosome membrane Peripheral membrane protein Cytoplasmic side. Cell projection, la |
|
| Protein Description | Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC). Can sense membrane curvature and has in vitro vesicle-to-membrane remodeling activity. Involved in retrograde endosome-to-TGN transport of lysosomal enzyme receptors (IGF2R, M6PR and SORT1). Plays a role in targeting ligand-activated EGFR to the lysosomes for degradation after endocytosis from the cell surface and release from the Golgi. Involvement in retromer-independent endocytic trafficking of P2RY1 and lysosomal degradation of protease-activated receptor-1/F2R. Promotes KALRN- and RHOG-dependent but retromer-independent membrane remodeling such as lamellipodium formation; the function is dependent on GEF activity of KALRN. Required for endocytosis of DRD5 upon agonist stimulation but not for basal receptor trafficking (By similarity).. | |
| Protein Sequence | MASGGGGCSASERLPPPFPGMDPESEGAAGASEPEAGDSDTEGEDIFTGAAAATKPQSPKKTTSLFPIKNGSKENGIHEDQDQEPQDLFADATVELSLDSTQNNQKTMPGKTLTSHSPQEATNSPKPQPSYEELEEEEQEDQFDLTVGITDPEKIGDGMNAYVAYKVTTQTSLPMFRSRQFAVKRRFSDFLGLYEKLSEKHSQNGFIVPPPPEKSLIGMTKVKVGKEDSSSAEFLEKRRAALERYLQRIVNHPTMLQDPDVREFLEKEELPRAVGTQALSGAGLLKMFNKATDAVSKMTIKMNESDIWFEEKLQEVECEEQRLRKLHAVVETLVNHRKELALNTALFAKSLAMLGSSEDNTALSRALSQLAEVEEKIEQLHQEQANNDSFLLAELLSDYIRLLAIVRAAFDQRMKTWQRWQDAQATLQKKRESEARLLWANKPDKLQQAKDEITEWESRVTQYERDFERISTVVRKEVTRFEKEKSKDFKNHVMKYLETLLHSQQQLAKYWEAFLPEAKAIS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 25 | Phosphorylation | FPGMDPESEGAAGAS CCCCCHHCCCCCCCC | 46.87 | 21082442 | |
| 32 | Phosphorylation | SEGAAGASEPEAGDS CCCCCCCCCCCCCCC | 53.41 | 21743459 | |
| 39 | Phosphorylation | SEPEAGDSDTEGEDI CCCCCCCCCCCCCCC | 45.58 | 21743459 | |
| 41 | Phosphorylation | PEAGDSDTEGEDIFT CCCCCCCCCCCCCCC | 50.25 | 21743459 | |
| 48 | Phosphorylation | TEGEDIFTGAAAATK CCCCCCCCCCHHCCC | 26.67 | 22817900 | |
| 54 | Phosphorylation | FTGAAAATKPQSPKK CCCCHHCCCCCCCCC | 38.23 | 22817900 | |
| 58 | Phosphorylation | AAATKPQSPKKTTSL HHCCCCCCCCCCCCC | 47.41 | 21743459 | |
| 72 | Phosphorylation | LFPIKNGSKENGIHE CEECCCCCCCCCCCC | 46.30 | 29514104 | |
| 117 | Phosphorylation | GKTLTSHSPQEATNS CCCCCCCCCCHHHCC | 28.22 | 28507225 | |
| 122 | Phosphorylation | SHSPQEATNSPKPQP CCCCCHHHCCCCCCC | 35.16 | 22807455 | |
| 124 | Phosphorylation | SPQEATNSPKPQPSY CCCHHHCCCCCCCCH | 29.91 | 22807455 | |
| 188 | Phosphorylation | FAVKRRFSDFLGLYE HHHHHHHHHHHHHHH | 26.16 | 26824392 | |
| 196 | Ubiquitination | DFLGLYEKLSEKHSQ HHHHHHHHHHHHHHC | 43.70 | - | |
| 229 | Phosphorylation | VKVGKEDSSSAEFLE EEECCCCCCHHHHHH | 27.55 | 19367708 | |
| 230 | Phosphorylation | KVGKEDSSSAEFLEK EECCCCCCHHHHHHH | 45.98 | 29176673 | |
| 231 | Phosphorylation | VGKEDSSSAEFLEKR ECCCCCCHHHHHHHH | 35.45 | 29176673 | |
| 237 | Acetylation | SSAEFLEKRRAALER CHHHHHHHHHHHHHH | 49.70 | 90447 | |
| 280 | Phosphorylation | AVGTQALSGAGLLKM HHHHHHHCHHHHHHH | 29.61 | 27180971 | |
| 286 | Ubiquitination | LSGAGLLKMFNKATD HCHHHHHHHHHHHHH | 46.63 | - | |
| 318 | S-palmitoylation | EKLQEVECEEQRLRK HHHHHCCCHHHHHHH | 9.36 | 28680068 | |
| 368 | Phosphorylation | TALSRALSQLAEVEE HHHHHHHHHHHHHHH | 23.35 | 26824392 | |
| 450 | Ubiquitination | PDKLQQAKDEITEWE CHHHHHHHHHHHHHH | 52.10 | - | |
| 463 | Phosphorylation | WESRVTQYERDFERI HHHHHHHHHHHHHHH | 11.99 | - | |
| 495 | Ubiquitination | DFKNHVMKYLETLLH HHHHHHHHHHHHHHH | 45.66 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNX1_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNX1_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNX1_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of SNX1_MOUSE !! | ||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188, AND MASSSPECTROMETRY. | |